Companies / Dr Reddys Laboratories Ltd

Dr Reddys Laboratories Ltd

NYSE: RDYCIK 1135951HYDERABADdrreddys.com ↗

Financials · FY2025

Revenue$3.81B
Net income$671.00M
Total debt—
Cash$172.00M
Diluted EPS$0.79
Shares outstanding834.7M

Ownership

834.7M shares outstanding
13.3%Institutions
Ownership
Institutions13.33%111,272,962
Public float86.67%723,384,008

% of common shares outstanding (single-class filing figure). Institutions are quarterly 13F snapshots; insiders reflect current officers & directors.

Insiders 19

View all →
Insider% of sharesShares
Aghanian Patrick RudolfHead - Europe Generics
——
Bhethanabottla Srinivasa PhanimitraChief Information Officer
——
Israeli ErezCEOCHIEF EXECUTIVE OFFICER
——
Kalawadia Milan KantilalCEOCEO - North America
——
Kodumudi Pranatharthi Haran KrishnanDirector
——
Kulkarni SushrutGLOBAL HEAD - IPDO
——
Kumar Arun MadhavanDirector
——
Mannam Venkata NarasimhamChief Financial Officer
——
Mehta Sanjiv SoshilDirector
——
Motupalli Venkata RamanaCEOCEO - Global Generics
——

Institutional holders 246

View all →
HolderValue% of shares
Robeco Institutional Asset Management B.V.$184.69M1.58%
BlackRock, Inc.$153.39M1.27%
Royal Bank of Canada$138.29M1.20%
Morgan Stanley$125.32M1.07%
Renaissance Technologies LLC$108.86M0.94%
Aikya Investment Management Ltd$103.03M0.88%
JPMorgan Chase & Co$76.76M0.66%
Dimensional Fund Advisors LP$75.22M0.64%
Vanguard Group Inc$70.58M0.60%
State Street Corporation$59.77M0.49%

Activity

Jun 30, 2026View all →
InsidersInstitutions
Who's accumulating and trimming this stock (13F).
DateActorActionSecurityValueShares ΔPosition afterImpact
Q1 2026
as of
AllianceBernstein L.P.
13F manager
AddADR$35.27M+2.5M
+8383.99%
2,541,889
0.30% of shares
medium
Q1 2026
as of
Marshall Wace, LLP
13F manager
AddADR$29.75M+2.1M
+416.08%
2,664,306
0.32% of shares
medium
Q1 2026
as of
BNP Paribas Financial Markets
13F manager
TrimADR$-13.42M-969K
-23.33%
3,183,971
0.38% of shares
medium
Q1 2026
as of
Royal Bank of Canada
13F manager
AddADR$6.02M+435K
+4.55%
9,984,082
1.20% of shares
medium
Q1 2026
as of
Renaissance Technologies LLC
13F manager
TrimADR$-5.48M-395K
-4.79%
7,859,728
0.94% of shares
medium
Q1 2026
as of
Grantham, Mayo, Van Otterloo & Co. LLC
13F manager
TrimADR$-4.37M-316K
-91.74%
28,441
<0.01% of shares
low
Q2 2026
as of
BlackRock, Inc.
13F manager
AddADR$4.17M+288K
+2.79%
10,585,742
1.27% of shares
low
Q2 2026
as of
Quadrature Capital Ltd
13F manager
AddADR$2.37M+163K
+960.14%
180,329
0.02% of shares
low

Securities

via CUSIP / OpenFIGI
SymbolTypeMarketCUSIPFIGI
RDYADREquity256135203BBG000NJ96L6